Cancer Prognostic Testing (IMAGE)

Georgetown University Medical Center

Cancer Prognostic Testing

Caption

Cancer prognostic tests such as Oncotype DX and MammaPrint appear to lower the cost of breast cancer care in the US. Such tests provide a score based on her tumor's molecular makeup that indicates when a woman can forgo expensive chemotherapy.

Credit

Genomic Health

Usage Restrictions

Seek permission from Genomic Health: Media@genomichealth.com

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.